SCIREX Corporation announced today the expansion of its European operations with the opening of a data management office in Krakow, Poland.
Krakow, Poland (PRWEB) April 6, 2005 -- SCIREX Corporation announced today the expansion of its European operations with the opening of a data management office in Krakow, Poland.
SCIREX Senior Vice President of Biometrics, Sharon Medendorp, cited Krakows highly educated labor pool and its central position in Europe as key factors in the decision to locate a SCIREX office in the city. A Krakow location supports the continued expansion of SCIREX throughout Europe, Medendorp stated. It provides our European clients high quality SCIREX services with geographical and temporal proximity between research sites and data management resources, meaningful cost advantages, and simplicity regarding compliance with the EU Clinical Trial Directive. The city is a pharmaceutical industry hub in Eastern Europe and is growing in importance, assisted by the increasing number of clinical trials being conducted in the region. Krakow thus provides us with a base from which to better service clients in Western Europe, and positions us well for growth opportunities in Eastern Europe."
Operations at SCIREXs Krakow facility will be overseen by Ryszarda Styczen, Senior Director of Data Management, and an eleven-year veteran of the company. Ms. Styczen will divide her time between her home base of Chicago, Illinois and Krakow. I look forward to bringing Krakow on-line in terms of our global data management systems, process and training, and I am confident our newest data management facility will make a considerable contribution to our clients success and to the success of our enterprise," she commented.
SCIREXs Krakow office will begin operations on 4 April, 2005 at the following address:
SCIREX Poland Sp. z o.o.
ul. Lubicz 23
31-503 Krakow
Poland
About SCIREX
SCIREX Corporation is a leader in the delivery of Phase I-IV drug development services to the global pharmaceutical and biotechnology industries. SCIREXs clinical trial management capabilities include drug development planning, protocol design, submission services, regulatory affairs consulting, investigator and patient recruitment, data management, statistics, medical writing and offers an array of technology solutions including IVRS, EDC and SIMSTM (Study Information Management System). SCIREXs experience portfolio includes more than 1,000 clinical trials involving well over 100,000 patients, evaluating new treatments for pain and inflammation, neurological and psychiatric disorders, infectious diseases and gastrointestinal and cardiovascular indications. SCIREX is a wholly-owned subsidiary of Omnicom Group, Inc. (NYSE: OMC).
For more information contact Ryszarda Styczen, Director of Data Management, at 630-307-1112 x6702, or visit www.scirex.com.
# # #
|
